These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5556285)

  • 1. Nonketoacidotic hyperglycemia and coma during intravenous diazoxide therapy in uremia.
    Charles MA; Danforth E
    Diabetes; 1971 Jul; 20(7):501-3. PubMed ID: 5556285
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyperglycemic coma without keto-acidosis in 2 hypertensive patients treated with intravenous diazoxide].
    Barjon P; Fourcade J; Monnier L; Mimran A; Taib J
    Sem Hop; 1973 Feb; 49(8):581-5. PubMed ID: 4349579
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous diazoxide for severe hypertension in childhood.
    McLaine PN; Drummond KN
    J Pediatr; 1971 Nov; 79(5):829-32. PubMed ID: 5116710
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute diabetic ketoacidosis--a complication of intravenous diazoxide treatment for refractory hypertension.
    Updike SJ; Harrington AR
    N Engl J Med; 1969 Apr; 280(14):768. PubMed ID: 4975231
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperglycemia after diazoxide.
    Danforth E
    N Engl J Med; 1971 Dec; 285(26):1487. PubMed ID: 5122901
    [No Abstract]   [Full Text] [Related]  

  • 6. The influences of rate of injection upon the effects of diazoxide.
    Johnson BF; Kapur M
    Am J Med Sci; 1972 Jun; 263(6):481-8. PubMed ID: 5050089
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of diazoxide in hypertensive crises with particular reference to the control of hypertension in severe renal failure.
    Mathew TH; Kincaid-Smith P
    Drugs; 1971; 2(2):73-7. PubMed ID: 5139210
    [No Abstract]   [Full Text] [Related]  

  • 8. Diazoxide and renal function in man.
    Johnson BF
    Clin Pharmacol Ther; 1971; 12(5):815-24. PubMed ID: 4936146
    [No Abstract]   [Full Text] [Related]  

  • 9. Diazoxide: a review of its pharmacological properties and therapeutic use in hypertensive crises.
    Drugs; 1971; 2(2):78-137. PubMed ID: 4336104
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperglycemic coma without ketoacidosis in 2 hypertensive patients treated with intravenous diazoxide].
    Barjon P; Fourcade J; Monnier L; Mimran A; Taib J
    Nouv Presse Med; 1972 Sep; 1(31):2048. PubMed ID: 5086767
    [No Abstract]   [Full Text] [Related]  

  • 11. The value of aggressive therapy in the hypertensive patient with azotemia.
    Mroczek WJ; Davidov M; Gavrilovich L; Finnerty FA
    Circulation; 1969 Dec; 40(6):893-904. PubMed ID: 5387363
    [No Abstract]   [Full Text] [Related]  

  • 12. Chlorthalidone-induced hyperosmolar hyperglycemic nonketotic coma.
    Curtis J; Horrigan F; Ahearn D; Varney R; Sandler SG
    JAMA; 1972 Jun; 220(12):1592-3. PubMed ID: 4624522
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antagonistic action of intestinal hormones and diazoxide on insulin secretion in humans].
    Raptis S; Schröder KE; Faulhaber JD; Pfeiffer EF
    Horm Metab Res; 1969 May; 1(3):116-21. PubMed ID: 4946718
    [No Abstract]   [Full Text] [Related]  

  • 14. AO44: an improved hyperglycemic agent.
    Lopez N; Basabe J; Grant A; Krees S; Terry M; Viktora J; Wolff F
    Metabolism; 1971 Apr; 20(4):373-83. PubMed ID: 5550304
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperosomolar coma in surgical patients: an latrogenic disease of increasing incidence.
    Brenner WI; Lansky Z; Engelman RM; Stahl WM
    Ann Surg; 1973 Nov; 178(5):651-4. PubMed ID: 4748304
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diabetogenic activity of diazoxide].
    Zahnd GR; Luyckx A
    Helv Med Acta Suppl; 1966 May; 46():163. PubMed ID: 5286273
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of diazoxide in hypertension with renal failure.
    Pohl JE; Thurston H
    Br Med J; 1971 Oct; 4(5780):142-5. PubMed ID: 5113016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental and clinical studies with diazoxide.
    Wolff F; Hirsch E; Wales J; Viktora J
    Ann N Y Acad Sci; 1968 Apr; 150(2):429-41. PubMed ID: 4875711
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperglycemia and inhibition of insulin secretion during administration of diazoxide and trichlormethiazide in man.
    Seltzer HS; Allen EW
    Diabetes; 1969 Jan; 18(1):19-28. PubMed ID: 5761863
    [No Abstract]   [Full Text] [Related]  

  • 20. Mode of action of a diazoxide analog (A025). Its effects on insulin secretion.
    Grant AM; Basabe JC; Lopez NL; Krees SV; Wolff FW
    Diabetes; 1970 Sep; 19(9):630-8. PubMed ID: 4990295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.